Related Experiment Video
Updated: Jun 1, 2026

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
Published on: August 4, 2018
Perioperative pharmacology: blood coagulation modifiers
Rodney W Hicks1, Linda J Wanzer, Bradlee Goeckner
1Uniformed Services University of the Health Sciences, Graduate School of Nursing, Bethesda, MD, USA.
Insights
Perioperative nurses must understand blood coagulation modifiers for patient safety. This includes knowing drug principles, lab results, and patient conditions for effective antithrombotic therapy management.
Area of Science:
- Pharmacology
- Nursing
- Hematology
Background:
- Blood coagulation is critical for hemostasis, preventing excessive bleeding from damaged vessels.
- Pharmacologic agents significantly influence the coagulation cascade.
- Evidence-based guidelines exist for managing antithrombotic therapy in the perioperative setting.
Purpose of the Study:
- To emphasize the essential role of perioperative nurses in managing blood coagulation modifiers.
- To highlight the need for nurses to understand the pharmacologic principles of these agents.
- To outline key nursing responsibilities in administering and monitoring coagulation therapy.
Main Methods:
- Review of American College of Chest Physicians' guidelines on perioperative antithrombotic therapy.
- Analysis of common blood coagulation modifiers used in perioperative care.
- Identification of essential nursing responsibilities related to these medications.
Main Results:
- Perioperative nurses require comprehensive knowledge of coagulation pharmacodynamics.
- Key nursing duties include interpreting laboratory values (PT, PTT, INR) and assessing patient conditions.
- Nurses play a vital role in documenting patient information and managing medication storage, such as for heparin.
Conclusions:
- Perioperative nurses must possess a strong understanding of blood coagulation and its pharmacologic modifiers.
- Effective management of antithrombotic therapy relies on nurses' ability to interpret data and apply evidence-based practices.
- Adherence to guidelines and meticulous documentation are crucial for patient safety in perioperative anticoagulation management.
Abstract:
Blood coagulation is the process that results in the formation of a blood clot to stop bleeding from a damaged blood vessel. Various pharmacologic agents can affect the coagulation process. The American College of Chest Physicians' evidence-based practice guidelines for perioperative management of antithrombotic therapy provide guidance for anticoagulant or antiplatelet therapy and bridge therapy. Perioperative nurses must understand the pharmacologic principles of the most common blood coagulation modifiers related to perioperative use. The perioperative nurse's responsibilities regarding administration of blood coagulation modifiers include reviewing the patient's pertinent laboratory results (eg, prothrombin time, partial thromboplastin time, international normalized ratio), recognizing the underlying conditions that require blood coagulation therapy, and documenting all pertinent information. Perioperative nurses also should participate in development of detailed storage and retrieval policies related to heparin.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
